- Home
- PDSB vs LPSN Comparison
PDSB vs LPSN Comparison
Compare PDSB & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- LPSN
- Stock Information
- Founded
- PDSB 2005
- LPSN 1995
- Country
- PDSB United States
- LPSN United States
- Employees
- PDSB N/A
- LPSN N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- LPSN EDP Services
- Sector
- PDSB Health Care
- LPSN Technology
- Exchange
- PDSB Nasdaq
- LPSN Nasdaq
- Market Cap
- PDSB 72.2M
- LPSN 72.8M
- IPO Year
- PDSB N/A
- LPSN 2000
- Fundamental
- Price
- PDSB $1.35
- LPSN $1.12
- Analyst Decision
- PDSB Strong Buy
- LPSN Hold
- Analyst Count
- PDSB 2
- LPSN 3
- Target Price
- PDSB $10.00
- LPSN $1.20
- AVG Volume (30 Days)
- PDSB 516.6K
- LPSN 1.4M
- Earning Date
- PDSB 08-12-2025
- LPSN 07-30-2025
- Dividend Yield
- PDSB N/A
- LPSN N/A
- EPS Growth
- PDSB N/A
- LPSN N/A
- EPS
- PDSB N/A
- LPSN N/A
- Revenue
- PDSB N/A
- LPSN $292,025,000.00
- Revenue This Year
- PDSB N/A
- LPSN N/A
- Revenue Next Year
- PDSB N/A
- LPSN $0.82
- P/E Ratio
- PDSB N/A
- LPSN N/A
- Revenue Growth
- PDSB N/A
- LPSN N/A
- 52 Week Low
- PDSB $0.85
- LPSN $0.58
- 52 Week High
- PDSB $4.42
- LPSN $2.08
- Technical
- Relative Strength Index (RSI)
- PDSB 41.32
- LPSN 72.90
- Support Level
- PDSB $1.18
- LPSN $0.88
- Resistance Level
- PDSB $1.66
- LPSN $1.14
- Average True Range (ATR)
- PDSB 0.11
- LPSN 0.08
- MACD
- PDSB -0.05
- LPSN 0.04
- Stochastic Oscillator
- PDSB 22.42
- LPSN 91.30
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.